Table 1.
Demographic and clinical characteristics of patients with anti-interferon-γ autoantibodies.
Table 2.
Laboratory biomarkers in patients with anti-interferon-γ autoantibodies: Comparison between active disease and remission.
Table 3.
Diagnostic performance metrics of Anti-IFN-γ autoantibody titers and inflammatory markers.
Fig 1.
ROC analysis of laboratory biomarker cut-off values for predicting active disease.
Table 4.
Performance of combined laboratory parameters in predicting disease.